Disease | cystic fibrosis |
Symptom | C0024115|lung disease |
Sentences | 65 |
PubMedID- 20693248 | Outcome measures to assess therapeutic interventions in cystic fibrosis (cf) patients with mild lung disease are lacking. |
PubMedID- 23460012 | As a result of their underlying lung disease, patients with cystic fibrosis (cf) have a higher risk of developing nontuberculous mycobacteria (ntm) infections compared with the general population. |
PubMedID- 22645424 | The pathogenesis of lung disease in cystic fibrosis is characterised by decreased airway surface liquid volume and subsequent failure of normal mucociliary clearance. |
PubMedID- 23743112 | Pseudomonas aeruginosa in patients without cystic fibrosis is strongly associated with chronic obstructive lung disease. |
PubMedID- 23748649 | Correlation between computed tomography expression of pulmonary hypertension and severity of lung disease in cystic fibrosis patients. |
PubMedID- 25963404 | Background: cystic fibrosis (cf) leads to advanced lung disease despite aggressive care. |
PubMedID- 19931415 | Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index. |
PubMedID- 23313410 | The use of ivacaftor in an adult with severe lung disease due to cystic fibrosis (deltaf508/g551d). |
PubMedID- 21955231 | lung disease in cystic fibrosis (cf) is typified by the development of chronic airways infection culminating in bronchiectasis and progression to end-stage respiratory disease. |
PubMedID- 23633344 | Background: nebuliser systems are used to deliver medications to control the symptoms and the progression of lung disease in people with cystic fibrosis. |
PubMedID- 22608703 | Background: it is not known whether antibiotic therapy for lung disease in cystic fibrosis (cf) has an influence on circulating polymorphonuclear neutrophil (pmn) function and apoptosis. |
PubMedID- 21942462 | Objective: guidelines recommend chronic use of tobramycin solution for inhalation (tsi) for cystic fibrosis (cf) patients with moderate-to-severe lung disease and persistent airway pseudomonas aeruginosa. |
PubMedID- 25505695 | These same challenges are likely to apply to treating infants, or adults with obstructed airways, with aerosolized gene vectors for other lung diseases.figure 3percent of people with cystic fibrosis by age with normal/mild forced expiratory volume in one second (fev1), moderate fev1and severe fev1. |
PubMedID- 26047144 | Background: lung disease in cystic fibrosis (cf) involves excessive inflammation, repetitive infections and development of bronchiectasis. |
PubMedID- 24429095 | Early lung disease in cystic fibrosis. |
PubMedID- 23226468 | The university of north carolina committee for the rights of human subjects approved the collection and use of excess surgical pathology tissue, obtained at the time of lung transplant, from patients with advanced lung disease associated with cystic fibrosis. |
PubMedID- 26079395 | Does the fef25-75 or the fef75 have any value in assessing lung disease in children with cystic fibrosis or asthma. |
PubMedID- 20435528 | Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research which areas to target. |
PubMedID- 20955240 | It is the main cause of hospital-acquired pneumonia and of lung disease in patients with cystic fibrosis, as well as infections in patients with neutropenia and burns (pier and ramphal, 2005). |
PubMedID- 20717938 | Summary: lung disease in patients with cystic fibrosis (cf) is characterized by recurrent bacterial respiratory infections and intense airway inflammation. |
PubMedID- 25339567 | Mycobacterial lung disease in patients with cystic fibrosis--report of three cases. |
PubMedID- 22538801 | Rationale: airways obstruction and lung volume restriction, major features of lung disease in cystic fibrosis (cf), may regress independently, causing dysanapsis between these parameters. |
PubMedID- 21220215 | Reports from the seventies and eighties have shown that cystic fibrosis (cf) patients with severe lung disease have high levels of igg and that this is associated with worse prognosis. |
PubMedID- 23076917 | Authors' conclusions: there is currently no evidence to support the use of cftr gene transfer reagents as a treatment for lung disease in people with cystic fibrosis. |
PubMedID- 25102015 | Antioxidant supplementation for lung disease in cystic fibrosis. |
PubMedID- 24671311 | Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis. |
PubMedID- 22960983 | What you don't know can hurt you; early asymptomatic lung disease in cystic fibrosis. |
PubMedID- 25629612 | Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis. |
PubMedID- 25070399 | We describe the case of a young patient with end-stage lung disease due to of cystic fibrosis and liver cirrhosis who needed combined lung-liver transplantation. |
PubMedID- 21382942 | cystic fibrosis and survival in patients with advanced lung disease. |
PubMedID- 22162514 | Regional differences in the evolution of lung disease in children with cystic fibrosis. |
PubMedID- 24062613 | Background: high-producer tgfbeta1 genotypes are associated with severe lung disease in cystic fibrosis (cf), but studies combining il-8, tnfalpha-, and tgfbeta1(+genotype) levels and their impact on cf lung disease are scarce. |
PubMedID- 21154377 | Antioxidant micronutrients for lung disease in cystic fibrosis. |
PubMedID- 19895389 | Lung transplantation is the only life-prolonging therapy available for cystic fibrosis (cf) patients with end-stage lung disease. |
PubMedID- 22241570 | Background: gastro-esophageal reflux (gor) may contribute to lung disease in children with cystic fibrosis (cf). |
PubMedID- 22431492 | Background: hypoxemia during sleep is a common finding in cystic fibrosis (cf) patients with more advanced lung disease. |
PubMedID- 25861303 | cystic fibrosis is associated with chronic lung disease, poor digestion, malabsorption of nutrients, and malnutrition 3. |
PubMedID- 22323305 | Rationale: unrecognized airway infection and inflammation in young children with cystic fibrosis (cf) may lead to irreversible lung disease; therefore early detection and treatment is highly desirable. |
PubMedID- 24884656 | Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease. |
PubMedID- 26022611 | Background: to assess the severity of lung disease in cystic fibrosis (cf), scoring systems based on chest radiographs (cxrs), ct and mri have been used extensively, although primarily in research settings rather than for clinical purposes. |
PubMedID- 20840889 | Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it. |
PubMedID- 26429870 | The purpose of this study was to evaluate cardiorespiratory fitness and reasons for exercise curtailment in a contemporary adult cystic fibrosis (cf) cohort with mild lung disease. |
PubMedID- 22035707 | We describe the successful use of ambulatory single-venous vv ecmo as a bridge to bilateral lung transplantation in 4 patients with end-stage lung disease due to cystic fibrosis who developed acute hypercapnic respiratory failure. |
PubMedID- 24282073 | Authors' conclusions: there is currently no evidence to support the use of cftr gene transfer agents as a treatment for lung disease in people with cystic fibrosis. |
PubMedID- 25478180 | Background: lung clearance index (lci) derived from sulfur hexafluoride (sf6) multiple breath washout (mbw) is a sensitive measure of lung disease in people with cystic fibrosis (cf). |
PubMedID- 25973994 | The spectrum of nocardia lung disease in cystic fibrosis. |
PubMedID- 25216826 | Mycobacterium abscessus complex is a group of rapidly growing mycobacteria, and an emerging cause of non-tuberculous mycobacterial lung disease in patients with cystic fibrosis and chronic lung diseases, such as bronchiectasis. |
PubMedID- 21494150 | Purpose of review: lung disease in cystic fibrosis (cf) results from chronic airway infection and inflammation leading to progressive bronchiectasis and respiratory failure. |
PubMedID- 24261460 | Rationale: previous studies of risk factors for progression of lung disease in cystic fibrosis (cf) have suffered from limitations that preclude a comprehensive understanding of the determinants of cf lung disease throughout childhood. |
PubMedID- 25124441 | lung disease in people with cystic fibrosis (cf) is initiated by defective host defense that predisposes airways to bacterial infection. |
Page: 1 2